People with head and neck cancer whose tumors have grown may live longer if they continue treatment with an immunotherapy drug that blocks a molecule that prevents T cells in the immune system from going after cancer cells, according to a recent study. Researchers are optimistic that immunotherapy already shows promise for melanoma and lung cancer, could also lead to better outcomes for head and neck cancer patients.

Source: The Elyria Chronicle newspaper Elyria, Ohio 6-18-2017 Daniel F. Hayes, M.D., President of the American Society of Clinical Oncology (ASCO) which presented new research at its annual meeting this month

PLEASE REMEMBER TO DONATE  THANK YOU!